CYP1A2 and early-onset autosomal dominant Alzheimer disease: Thus, the upregulation of miR-122 and/or miR-132-5p may be associated with decreased activity of CYP1A2 at the transcript, protein, and enzyme activity levels, which could have therapeutic potential in Alzheimer's disease.